X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs LUPIN LTD - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD LUPIN LTD WYETH LTD/
LUPIN LTD
 
P/E (TTM) x 27.7 19.9 139.2% View Chart
P/BV x 5.3 2.7 198.3% View Chart
Dividend Yield % 1.3 0.9 137.1%  

Financials

 WYETH LTD   LUPIN LTD
EQUITY SHARE DATA
    WYETH LTD
Mar-13
LUPIN LTD
Mar-17
WYETH LTD/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1,0441,750 59.7%   
Low Rs8181,384 59.1%   
Sales per share (Unadj.) Rs298.6387.4 77.1%  
Earnings per share (Unadj.) Rs57.256.6 101.1%  
Cash flow per share (Unadj.) Rs58.476.8 76.0%  
Dividends per share (Unadj.) Rs17.007.50 226.7%  
Dividend yield (eoy) %1.80.5 381.4%  
Book value per share (Unadj.) Rs249.5298.9 83.5%  
Shares outstanding (eoy) m22.72451.58 5.0%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x3.14.0 77.1%   
Avg P/E ratio x16.327.7 58.8%  
P/CF ratio (eoy) x15.920.4 78.2%  
Price / Book Value ratio x3.75.2 71.2%  
Dividend payout %29.713.2 224.3%   
Avg Mkt Cap Rs m21,157707,513 3.0%   
No. of employees `0000.516.8 2.9%   
Total wages/salary Rs m40028,495 1.4%   
Avg. sales/employee Rs Th13,787.410,418.3 132.3%   
Avg. wages/employee Rs Th813.01,697.0 47.9%   
Avg. net profit/employee Rs Th2,643.31,523.0 173.6%   
INCOME DATA
Net Sales Rs m6,783174,943 3.9%  
Other income Rs m3531,065 33.1%   
Total revenues Rs m7,136176,008 4.1%   
Gross profit Rs m1,61744,931 3.6%  
Depreciation Rs m279,122 0.3%   
Interest Rs m61,525 0.4%   
Profit before tax Rs m1,93835,349 5.5%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6329,785 6.5%   
Profit after tax Rs m1,30125,575 5.1%  
Gross profit margin %23.825.7 92.8%  
Effective tax rate %32.627.7 117.9%   
Net profit margin %19.214.6 131.1%  
BALANCE SHEET DATA
Current assets Rs m6,984119,542 5.8%   
Current liabilities Rs m2,05661,206 3.4%   
Net working cap to sales %72.633.3 217.9%  
Current ratio x3.42.0 173.9%  
Inventory Days Days9976 130.6%  
Debtors Days Days2490 26.6%  
Net fixed assets Rs m244131,660 0.2%   
Share capital Rs m227903 25.2%   
"Free" reserves Rs m5,441134,073 4.1%   
Net worth Rs m5,668134,976 4.2%   
Long term debt Rs m2556,478 0.0%   
Total assets Rs m7,901266,073 3.0%  
Interest coverage x353.324.2 1,461.5%   
Debt to equity ratio x00.4 1.1%  
Sales to assets ratio x0.90.7 130.6%   
Return on assets %16.510.2 162.3%  
Return on equity %22.918.9 121.1%  
Return on capital %34.019.3 176.7%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1581,885 0.0%   
Fx outflow Rs m2,67721,506 12.4%   
Net fx Rs m-2,66260,378 -4.4%   
CASH FLOW
From Operations Rs m92341,148 2.2%  
From Investments Rs m317-25,287 -1.3%  
From Financial Activity Rs m-4814,332 -11.1%  
Net Cashflow Rs m75920,193 3.8%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 51.1 0.2 25,550.0%  
Indian inst/Mut Fund % 11.3 11.3 100.0%  
FIIs % 7.2 31.9 22.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 10.1 301.0%  
Shareholders   21,978 98,259 22.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  PANACEA BIOTECH  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS